Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Tiwari, Neha ^a,c   Meyer Schaller, Nathalie ^a   Arnold, Phil ^b   Antoniadis, Helena ^a   Pachkov, Mikhail ^b   van Nimwegen, Erik ^b   Christofori, Gerhard ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ENDOTHELIN 1; KRUPPEL LIKE FACTOR 4; NERVE CELL ADHESION MOLECULE; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VASCULOTROPIN A; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER PATIENT; CANCER SURVIVAL; CDH1 GENE; CDH2 GENE; CELL DIFFERENTIATION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CTNNB1 GENE; DISEASE FREE SURVIVAL; DOWN REGULATION; EDN1 GENE; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MAPK8 GENE; METASTASIS; MOUSE; NONHUMAN; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; VEGFA GENE; VIM GENE;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; NEOPLASMS, EXPERIMENTAL; TRANS-ACTIVATORS;

EID: 84874366011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057329     Document Type: Article

References (49)

1. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
2. Christofori G, (2006) New signals from the invasive front. Nature 441: 444-450.
3. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T, (2005) Opinion: migrating cancer stem cells- an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
4. Grunert S, Jechlinger M, Beug H, (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4: 657-665.
5. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
6. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
7. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
8. Yilmaz M, Maass D, Tiwari N, Waldmeier L, Schmidt P, et al. (2011) Transcription factor Dlx2 protects from TGFbeta-induced cell-cycle arrest and apoptosis. EMBO J 30: 4489-4499.
9. Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, et al. (2008) NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J 27: 2603-2615.
10. Shields JM, Christy RJ, Yang VW, (1996) Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 271: 20009-20017.
11. Dang DT, Bachman KE, Mahatan CS, Dang LH, Giardiello FM, et al. (2000) Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett 476: 203-207.
12. Katz JP, Perreault N, Goldstein BG, Actman L, McNally SR, et al. (2005) Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128: 935-945.
13. Ohnishi S, Ohnami S, Laub F, Aoki K, Suzuki K, et al. (2003) Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun 308: 251-256.
14. Shie JL, Chen ZY, O'Brien MJ, Pestell RG, Lee ME, et al. (2000) Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation. Am J Physiol Gastrointest Liver Physiol 279: G806-814.
15. Ton-That H, Kaestner KH, Shields JM, Mahatanankoon CS, Yang VW, (1997) Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis. FEBS Lett 419: 239-243.
16. Wei D, Gong W, Kanai M, Schlunk C, Wang L, et al. (2005) Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 65: 2746-2754.
17. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, et al. (2004) Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23: 395-402.
18. Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, et al. (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res 60: 6488-6495.
19. Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, et al. (2005) Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24: 1491-1500.
20. Foster KW, Ren S, Louro ID, Lobo-Ruppert SM, McKie-Bell P, et al. (1999) Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Diff 10: 423-434.
21. Akaogi K, Nakajima Y, Ito I, Kawasaki S, Oie SH, et al. (2009) KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha. Oncogene 28: 2894-2902.
22. Rowland BD, Bernards R, Peeper DS, (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7: 1074-1082.
23. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
24. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
25. Segre JA, Bauer C, Fuchs E, (1999) Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22: 356-360.
26. Yori JL, Johnson E, Zhou G, Jain MK, Keri RA, (2010) Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 285: 16854-16863.
27. Waldmeier L, Meyer-Schaller N, Diepenbruck M, Christofori G, (2012) Py2T Murine Breast Cancer Cells, a Versatile Model of TGFbeta-Induced EMT In Vitro and In Vivo. PloS One 7: e48651.
28. Deckers M, van Dinther M, Buijs J, Que I, Lowik C, et al. (2006) The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66: 2202-2209.
29. Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L, (1995) Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1: 1029-1034.
30. Ivshina AV, George J, Senko O, Mow B, Putti TC, et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301.
31. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13: 3207-3214.
32. Chen X, Johns DC, Geiman DE, Marban E, Dang DT, et al. (2001) Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem 276: 30423-30428.
33. Yu F, Li J, Chen H, Fu J, Ray S, et al. (2011) Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30: 2161-2172.
34. Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, et al. (2011) Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 13: 601-610.
35. Li R, Liang J, Ni S, Zhou T, Qing X, et al. (2010) A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7: 51-63.
36. Derijard B, Hibi M, Wu IH, Barrett T, Su B, et al. (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037.
37. Tournier C, Hess P, Yang DD, Xu J, Turner TK, et al. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874.
38. Santibanez JF, (2006) JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett 580: 5385-5391.
39. Alcorn JF, Guala AS, van der Velden J, McElhinney B, Irvin CG, et al. (2008) Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci 121: 1036-1045.
40. van der Velden JL, Alcorn JF, Guala AS, Badura EC, Janssen-Heininger YM, (2010) c-Jun N-Terminal Kinase 1 Promotes TGF-{beta}1-induced Epithelial to Mesenchymal Transition via Control of Linker Phosphorylation and Transcriptional Activity of Smad3. Am J Resp Cell Mol Biol 47: 306-314.
41. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K, (2003) JNK phosphorylates paxillin and regulates cell migration. Nature 424: 219-223.
42. Cellurale C, Girnius N, Jiang F, Cavanagh-Kyros J, Lu S, et al. (2012) Role of JNK in mammary gland development and breast cancer. Cancer Res 72: 472-481.
43. Cellurale C, Weston CR, Reilly J, Garlick DS, Jerry DJ, et al. (2010) Role of JNK in a Trp53-dependent mouse model of breast cancer. PloS One 5: e12469.
44. Chen P, O'Neal JF, Ebelt ND, Cantrell MA, Mitra S, et al. (2010) Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model. PloS One 5: e10443.
45. Maeda M, Johnson KR, Wheelock MJ, (2005) Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118: 873-887.
46. Takahashi K, Okita K, Nakagawa M, Yamanaka S, (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat Protocols 2: 3081-3089.
47. Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, et al. (2006) Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res 66: 7509-7515.
48. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, et al. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genetics 39: 457-466.
49. Tiwari VK, Stadler MB, Wirbelauer C, Paro R, Schubeler D, et al. (2012) A chromatin-modifying function of JNK during stem cell differentiation. Nat Genetics 44: 94-100.